Lee Seo In, Hong Kyung Sook, Park Jin, Lee Young-Joo
Department of Critical Care Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
Department of Surgery and Critical Care Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
Acute Crit Care. 2020 Aug;35(3):179-188. doi: 10.4266/acc.2020.00136. Epub 2020 Aug 10.
This study examined the experience of withholding or withdrawing life-sustaining treatment in patients hospitalized in the intensive care units (ICUs) of a tertiary care center. It also considers the role that intensivists play in the decision-making process regarding the withdrawal of life-sustaining treatment.
We retrospectively analyzed the medical records of 227 patients who decided to withhold or withdraw life-sustaining treatment while hospitalized at Ewha Womans University Medical Center Mokdong between April 9 and December 31, 2018.
The 227 hospitalized patients included in the analysis withheld or withdrew from life-sustaining treatment. The department in which life-sustaining treatment was withheld or withdrawn most frequently was hemato-oncology (26.4%). Among these patients, the most common diagnosis was gastrointestinal tract cancer (29.1%). A majority of patients (64.3%) chose not to receive any life-sustaining treatment. Of the 80 patients in the ICU, intensivists participated in the decision to withhold or withdraw life-sustaining treatment in 34 cases. There were higher proportions of treatment withdrawal and ICU-to-ward transfers among the cases in whom intensivists participated in decision making compared to those cases in whom intensivists did not participate (50.0% vs. 4.3% and 52.9% vs. 19.6%, respectively).
Through their participation in end-of-life discussions, intensivists can help patients' families to make decisions about withholding or withdrawing life-sustaining treatment and possibly avoiding futile treatments for these patients.
本研究调查了在一家三级医疗中心的重症监护病房(ICU)住院的患者中,停止或撤销维持生命治疗的情况。同时也探讨了重症医学专家在维持生命治疗撤销决策过程中所起的作用。
我们回顾性分析了2018年4月9日至12月31日在梨花女子大学木洞医学中心住院期间决定停止或撤销维持生命治疗的227例患者的病历。
纳入分析的227例住院患者停止或撤销了维持生命治疗。停止或撤销维持生命治疗最频繁的科室是血液肿瘤科(26.4%)。在这些患者中,最常见的诊断是胃肠道癌(29.1%)。大多数患者(64.3%)选择不接受任何维持生命的治疗。在80例入住ICU的患者中,重症医学专家参与了34例停止或撤销维持生命治疗的决策。与重症医学专家未参与决策的病例相比,重症医学专家参与决策的病例中治疗撤销和从ICU转至普通病房的比例更高(分别为50.0%对4.3%以及52.9%对19.6%)。
通过参与临终讨论,重症医学专家可以帮助患者家属做出关于停止或撤销维持生命治疗的决策,并可能避免对这些患者进行无效治疗。